How to deliver personalized cardiac resynchronization therapy through the precise measurement of the acute hemodynamic response: Insights from the iSpot trial.
Matthew J Shun-ShinAlejandra A MiyazawaDaniel KeeneMaciej SterlińskiAdam SokalFrédéric Van HeuverswynChristopher A RinaldiRichard CornelussenBerthold StegemannDarrel P FrancisZachary WhinnettPublished in: Journal of cardiovascular electrophysiology (2019)
Current standard multibeat acquisition protocols are unfortunately unable to prevent false impressions of optimality arising in individual patients. Personalization processes need to include distinct repeated transitions to the tested pacing configuration in addition to averaging multiple beats. The need is not only during research stages but also during clinical implementation.
Keyphrases
- cardiac resynchronization therapy
- end stage renal disease
- left ventricular
- heart failure
- ejection fraction
- newly diagnosed
- primary care
- chronic kidney disease
- healthcare
- prognostic factors
- peritoneal dialysis
- liver failure
- study protocol
- atrial fibrillation
- patient reported outcomes
- respiratory failure
- acute respiratory distress syndrome
- patient reported
- rare case